Literature DB >> 25157798

Reduced responses to heroin-cue-induced craving in the dorsal striatum: effects of long-term methadone maintenance treatment.

Yarong Wang1, Hanyue Wang2, Wei Li2, Jia Zhu2, Mark S Gold3, Dongsheng Zhang2, Lina Wang2, Yongbin Li2, Xuejiao Yan2, Jiajie Cheng2, Qiang Li4, Wei Wang5.   

Abstract

Methadone maintenance treatment (MMT) is safe and effective for heroin addiction, but the neural basis of the length effects of long-term MMT on brain activity during craving in former heroin addicts is unclear. This study explored it by comparing the brain activations of heroin addicts with different length of MMT during pictorial presentation of heroin-related cue. Fifteen male former heroin addicts successfully treated by MMT less than 1 year (Group A), 15 matched patients with 2-3 year MMT (Group B) and 17 healthy controls underwent functional magnetic resonance imaging while heroin-related and neutral stimuli were present to them. Subjective cue-elicited craving was measured with visual analog scale before and after imaging. Then, partial correlation analysis to reveal the relationship between drug-related blood oxygen level dependent (BOLD) signal intensity and heroin or methadone use history. Finally, self-reported craving was not different between Group A and B before and after scanning. Compared with Group A, Group B had a significant reduced brain activity to heroin-related minus neural cues in the bilateral caudate. After controlling for the variable heroin use history, the drug-related BOLD signal intensity in the bilateral caudate was negatively correlated with MMT duration and total methadone consumption. When MMT history was controlled, the drug-related activity intensity in right caudate had a positive correlation with heroin daily dosage. Long-term MMT may improve heroin-craving response by modulating the impaired function in the bilateral dorsal striatum caused by former heroin use.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Craving, Caudate, Functional magnetic imaging (fMRI); Heroin addiction; Methadone maintenance treatment (MMT)

Mesh:

Substances:

Year:  2014        PMID: 25157798     DOI: 10.1016/j.neulet.2014.08.026

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  16 in total

1.  Extended exposure to environmental cues, but not to sucrose, reduces sucrose cue reactivity in rats.

Authors:  John H Harkness; Jason Wells; Sierra Webb; Jeffrey W Grimm
Journal:  Learn Behav       Date:  2016-03       Impact factor: 1.986

2.  Intact responses to non-drug rewards in long-term opioid maintenance treatment.

Authors:  Marie Eikemo; Philipp P Lobmaier; Mads L Pedersen; Nikolaj Kunøe; Anna Maria Matziorinis; Siri Leknes; Monica Sarfi
Journal:  Neuropsychopharmacology       Date:  2019-03-31       Impact factor: 7.853

Review 3.  Neuroimaging the Effectiveness of Substance Use Disorder Treatments.

Authors:  Elizabeth A Cabrera; Corinde E Wiers; Elsa Lindgren; Gregg Miller; Nora D Volkow; Gene-Jack Wang
Journal:  J Neuroimmune Pharmacol       Date:  2016-05-16       Impact factor: 4.147

4.  Neuroimaging Impaired Response Inhibition and Salience Attribution in Human Drug Addiction: A Systematic Review.

Authors:  Anna Zilverstand; Anna S Huang; Nelly Alia-Klein; Rita Z Goldstein
Journal:  Neuron       Date:  2018-06-06       Impact factor: 17.173

Review 5.  The thalamus in drug addiction: from rodents to humans.

Authors:  Anna S Huang; Jameson A Mitchell; Suzanne N Haber; Nelly Alia-Klein; Rita Z Goldstein
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2018-03-19       Impact factor: 6.237

6.  Anhedonia as a key clinical feature in the maintenance and treatment of opioid use disorder.

Authors:  Brian D Kiluk; Sarah W Yip; Elise E DeVito; Kathleen M Carroll; Mehmet Sofuoglu
Journal:  Clin Psychol Sci       Date:  2019-09-23

7.  Prefrontal cortex response to drug cues, craving, and current depressive symptoms are associated with treatment outcomes in methadone-maintained patients.

Authors:  Andrew S Huhn; Mary M Sweeney; Robert K Brooner; Michael S Kidorf; D Andrew Tompkins; Hasan Ayaz; Kelly E Dunn
Journal:  Neuropsychopharmacology       Date:  2018-10-30       Impact factor: 7.853

8.  Can neuroimaging help combat the opioid epidemic? A systematic review of clinical and pharmacological challenge fMRI studies with recommendations for future research.

Authors:  Hestia Moningka; Sarah Lichenstein; Patrick D Worhunsky; Elise E DeVito; Dustin Scheinost; Sarah W Yip
Journal:  Neuropsychopharmacology       Date:  2018-10-03       Impact factor: 7.853

9.  A serotonergic biobehavioral signature differentiates cocaine use disorder participants administered mirtazapine.

Authors:  Liangsuo Ma; Kathryn A Cunningham; Noelle C Anastasio; James M Bjork; Brian A Taylor; Albert J Arias; Brien P Riley; Andrew D Snyder; F Gerard Moeller
Journal:  Transl Psychiatry       Date:  2022-05-06       Impact factor: 7.989

10.  Differences in cue-induced brain activation between long-term methadone maintenance treatment and protracted abstinence in heroin use disorder patients: a functional magnetic resonance imaging study.

Authors:  Xuan Wei; Qiang Li; Jiajie Chen; Baorui Shen; Wei Wang; Wei Li
Journal:  Quant Imaging Med Surg       Date:  2021-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.